Long non-coding RNAs in cutaneous melanoma: clinical perspectives.
about
MiR-219-5p Inhibits the Growth and Metastasis of Malignant Melanoma by Targeting BCL-2.Expression profiles analysis of long non-coding RNAs identified novel lncRNA biomarkers with predictive value in outcome of cutaneous melanoma.Survival prediction of kidney renal papillary cell carcinoma by comprehensive LncRNA characterization.A six-long non-coding RNA signature predicts prognosis in melanoma patients.
P2860
Long non-coding RNAs in cutaneous melanoma: clinical perspectives.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Long non-coding RNAs in cutaneous melanoma: clinical perspectives.
@en
Long non-coding RNAs in cutaneous melanoma: clinical perspectives.
@nl
type
label
Long non-coding RNAs in cutaneous melanoma: clinical perspectives.
@en
Long non-coding RNAs in cutaneous melanoma: clinical perspectives.
@nl
prefLabel
Long non-coding RNAs in cutaneous melanoma: clinical perspectives.
@en
Long non-coding RNAs in cutaneous melanoma: clinical perspectives.
@nl
P2093
P2860
P921
P356
P1433
P1476
Long non-coding RNAs in cutaneous melanoma: clinical perspectives
@en
P2093
Eva Hulstaert
Lieve Brochez
Pieter Mestdagh
Pieter-Jan Volders
P2860
P304
43470-43480
P356
10.18632/ONCOTARGET.16478
P407
P5008
P577
2017-06-01T00:00:00Z